Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -11.86% is 50% below its 5-year average of -7.89%, near the high end of its 5-year range (-231.19%–8.34%).
1.48% below its 12-month average of -11.69%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -12.80%.
NET PROFIT MARGIN
-11.86%
NET PROFIT MARGIN AVG TTM
-11.69%
NET PROFIT MARGIN AVG 3Y
-10.57%
NET PROFIT MARGIN AVG 5Y
-7.89%
NET PROFIT MARGIN AVG 10Y
-6.04%
NET PROFIT MARGIN AVG 15Y
-2.72%
NET PROFIT MARGIN AVG 20Y
-1.79%
CURRENT VS TTM AVG
-1.48%
CURRENT VS 3Y AVG
-12.25%
CURRENT VS 5Y AVG
-50.26%
CURRENT VS 10Y AVG
-96.20%
CURRENT VS 15Y AVG
-335.72%
CURRENT VS 20Y AVG
-561.75%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-4461.54%
vs the sector median at left
Harvard Bioscience, Inc.
Market Cap
$38.81M
Net Profit Margin
-11.86%
TTM Avg
-11.69%
3Y Avg
-10.57%
5Y Avg
-7.89%
Market Cap
$39.06M
Net Profit Margin
-689.20%
TTM Avg
-248.90%
3Y Avg
-225.94%
5Y Avg
-1945.52%
Market Cap
$37.94M
Net Profit Margin
0.00%
TTM Avg
-27258.72%
3Y Avg
-52085.61%
5Y Avg
-35139.97%
Market Cap
$37.89M
Net Profit Margin
8.38%
TTM Avg
3.43%
3Y Avg
-19.55%
5Y Avg
-29.01%
Market Cap
$40.39M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$36.99M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-322.60%
Market Cap
$36.42M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-479.12%
Market Cap
$41.30M
Net Profit Margin
0.00%
TTM Avg
-111.93%
3Y Avg
-252.09%
5Y Avg
-173.47%
Market Cap
$36.28M
Net Profit Margin
-65.31%
TTM Avg
-147.78%
3Y Avg
-3852.20%
5Y Avg
-3378.36%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $38.81M | -11.86% | -11.69% | -10.57% | -7.89% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.06M | -689.20% | -248.90% | -225.94% | -1945.52% |
| Incannex Healthcare Limited (IXHL)vs › | $37.94M | 0.00% | -27258.72% | -52085.61% | -35139.97% |
| Nephros, Inc. (NEPH)vs › | $37.89M | 8.38% | 3.43% | -19.55% | -29.01% |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.39M | 0.00% | 0.00% | 0.00% | 0.00% |
| Edesa Biotech, Inc. (EDSA)vs › | $36.99M | 0.00% | 0.00% | 0.00% | -322.60% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.42M | 0.00% | 0.00% | 0.00% | -479.12% |
| Veru Inc. (VERU)vs › | $41.30M | 0.00% | -111.93% | -252.09% | -173.47% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.28M | -65.31% | -147.78% | -3852.20% | -3378.36% |
| EUDA Health Holdings Limited (EUDA)vs › | $35.69M | -40.49% | -211.76% | -338.86% | -222.41% |
Operating Margin
1.2%
Net Profit Margin
-11.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -12.80% |
| 2026-03-31 | -16.50% |
| 2025-12-31 | -11.99% |
| 2025-09-30 | -5.98% |
| 2025-06-30 | -11.16% |
| 2025-03-31 | -231.19% |
| 2024-12-31 | 0.07% |
| 2024-09-30 | -21.86% |
| 2024-06-30 | -12.67% |
| 2024-03-31 | -19.15% |
| 2023-12-31 | -6.46% |
| 2023-09-30 | -4.89% |
| 2023-06-30 | -3.41% |
| 2023-03-31 | 2.08% |
| 2022-12-31 | -5.86% |
| 2022-09-30 | -12.65% |
| 2022-06-30 | 8.34% |
| 2022-03-31 | -23.91% |
| 2021-12-31 | 2.91% |
| 2021-09-30 | -0.57% |
| 2021-06-30 | -1.40% |
| 2021-03-31 | -2.48% |
| 2020-12-31 | -1.98% |
| 2020-09-30 | -4.57% |
| 2020-06-30 | -6.78% |
| 2020-03-31 | -19.00% |
| 2019-12-31 | 1.78% |
| 2019-09-30 | -9.56% |
| 2019-06-30 | -0.83% |
| 2019-03-31 | -8.40% |
| 2018-12-31 | 6.86% |
| 2018-09-30 | -0.89% |
| 2018-06-30 | -4.64% |
| 2018-03-31 | -15.19% |
| 2017-12-31 | 3.64% |
| 2017-09-30 | -1.66% |
| 2017-06-30 | -1.51% |
| 2017-03-31 | -4.41% |
| 2016-12-31 | -5.00% |
| 2016-09-30 | -6.55% |
| 2016-06-30 | -2.73% |
| 2016-03-31 | -2.36% |
| 2015-12-31 | -60.42% |
| 2015-09-30 | -3.29% |
| 2015-06-30 | 1.21% |
| 2015-03-31 | -5.44% |
| 2014-12-31 | -0.06% |
| 2014-09-30 | 2.49% |
| 2014-06-30 | 3.79% |
| 2014-03-31 | 2.78% |
| 2013-12-31 | -2.71% |
| 2013-09-30 | -3.91% |
| 2013-06-30 | -0.71% |
| 2013-03-31 | 0.37% |
| 2012-12-31 | 4.26% |
| 2012-09-30 | -0.51% |
| 2012-06-30 | 2.72% |
| 2012-03-31 | 1.87% |
| 2011-12-31 | 2.54% |
| 2011-09-30 | 0.11% |
| 2011-06-30 | 5.05% |
| 2011-03-31 | 6.37% |
| 2010-12-31 | 7.39% |
| 2010-09-30 | 48.12% |
| 2010-06-30 | 7.27% |
| 2010-03-31 | 8.44% |
| 2009-12-31 | 13.71% |
| 2009-09-30 | 6.29% |
| 2009-06-30 | 1.56% |
| 2009-03-31 | 9.64% |
| 2008-12-31 | 9.01% |
| 2008-09-30 | 7.17% |
| 2008-06-30 | -9.57% |
| 2008-03-31 | 3.13% |
| 2007-12-31 | -5.31% |
| 2007-09-30 | 6.30% |
| 2007-06-30 | -8.65% |
| 2007-03-31 | 2.59% |
| 2006-12-31 | -10.97% |
| 2006-09-30 | -0.95% |
| 2006-06-30 | -1.78% |
| 2006-03-31 | 3.11% |
| 2005-12-31 | -30.05% |
| 2005-09-30 | 3.85% |
| 2005-06-30 | -126.03% |
| 2005-03-31 | 0.90% |
| 2004-12-31 | 4.55% |
| 2004-09-30 | 4.12% |
| 2004-06-30 | 1.33% |
| 2004-03-31 | -0.23% |
| 2003-12-31 | 7.24% |
| 2003-09-30 | 4.67% |
| 2003-06-30 | 3.32% |
| 2003-03-31 | 3.99% |
| 2002-12-31 | -5.14% |
| 2002-09-30 | -0.64% |
